These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 425796)

  • 41. [Surgical treatment of colorectal cancer. Value of immunologic competence skin tests in the prognostic and immunotherapeutic evaluation].
    de Godoy AC; Crema E; Goffi FS; Aun WC; Salles VL; de Mello JF
    Rev Paul Med; 1983; 101(3):91-5. PubMed ID: 6648227
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients.
    Jessup JM; Giavazzi R; Campbell D; Cleary K; Morikawa K; Fidler IJ
    Cancer Res; 1988 Mar; 48(6):1689-92. PubMed ID: 3345536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer.
    Zamcheck N
    Clin Gastroenterol; 1976 Sep; 5(3):625-38. PubMed ID: 1022377
    [No Abstract]   [Full Text] [Related]  

  • 44. The follow-up of patients after resection for large bowel cancer, May 1992. Colorectal Surgical Society of Australia.
    Collopy BT
    Med J Aust; 1992 Nov; 157(9):633-4. PubMed ID: 1492875
    [No Abstract]   [Full Text] [Related]  

  • 45. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
    Safi F; Rappenecker B; Roscher R; Beger HG
    Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation of single and serial CEA determinations with the clinical evolution of cancer patients.
    de Levin RW; Levin E
    Arch Geschwulstforsch; 1982; 52(2):105-12. PubMed ID: 7103688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma carcinoembryonic antigen (CEA), tumor CEA, and tumor histology.
    Boyd CR; Bivins BA; Kashmiri R; Parker JC; Meeker WR
    Surg Forum; 1975; 26():124-6. PubMed ID: 1216084
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of tumor markers in the management of colorectal cancer.
    Go VL; Zamcheck N
    Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoiperative carcinoembryonic antigen level and prognosis in colorectal cancer.
    Chapuis PH; Newland RC; Payne JE; Macpherson JG; Pheils MT
    Med J Aust; 1980 Aug; 2(3):140-3. PubMed ID: 7421682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma.
    Kåresen R; Hertzberg J; Johannesen J; Thoresen BO; Orjasaeter H
    Am J Proctol Gastroenterol Colon Rectal Surg; 1980 Nov; 31(11):18-22. PubMed ID: 7212050
    [No Abstract]   [Full Text] [Related]  

  • 51. [The carcinoembryonic antigen level as an indicator for second look operations].
    Halevy A; Adam Y; Eschar J; Zaidman J; Sherf S
    Harefuah; 1980 Aug; 99(3-4):59-61. PubMed ID: 7203206
    [No Abstract]   [Full Text] [Related]  

  • 52. [Significance of carcinoembryonic antigen in the treatment of colorectal cancers].
    Putzki H
    Zentralbl Chir; 1986; 111(18):1119-23. PubMed ID: 3788331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein markers in disease (3). Carcinoembryonic antigen as a tumour marker.
    Sturgeon CM
    J R Coll Surg Edinb; 1978 Sep; 23(5):319-25. PubMed ID: 702421
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical aids to cancer management.
    Cooper EH
    Recent Results Cancer Res; 1977; (62):36-8. PubMed ID: 23570
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical application of radioimmunolocalization in colorectal cancer].
    Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
    Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Carcinoembryonic antigen level in the monitoring of patients with surgically excised rectocolonic tumors].
    Vosse-Matagne G; Desaive C
    Rev Med Liege; 1979 Apr; 34(7):256-60. PubMed ID: 441601
    [No Abstract]   [Full Text] [Related]  

  • 58. [The use of CEA radioimmunoassay for the detection of recurrence of carcinoma of the large bowel (author's transl)].
    Jaquet H; Mach JP; Pettavel J
    Langenbecks Arch Chir; 1976 Nov; 342():243-9. PubMed ID: 994637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoembryonic antigen: its role in the management of colorectal cancer.
    Kilfoyle RG; Andersen CA
    Mil Med; 1983 Jul; 148(7):589-90. PubMed ID: 6413891
    [No Abstract]   [Full Text] [Related]  

  • 60. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.
    Elias EG; Holyoke ED; Chu TM
    Dis Colon Rectum; 1974; 17(1):38-41. PubMed ID: 4204181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.